Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Emoxypine succinate (Mexidol) is a non-peptide small-molecule 3-hydroxypyridine derivative, the succinate salt of 2-ethyl-6-methyl-3-hydroxypyridine. It is a registered prescription drug in Russia and CIS states since the 1990s (IV/IM solution and oral tablet forms) but is NOT approved by the FDA or EMA. In the US and EU, it is sold only as an unregulated research chemical by nootropic vendors, typically labeled "not for human consumption." A 2024 peer-reviewed analysis flags its antihypoxic/metabolic-modulator profile as pharmacologically similar to WADA-banned agents meldonium and trimetazidine, documents past use by Russian athletes, and identifies it as a candidate for future prohibited-list consideration—though it is not currently WADA-prohibited.
Verified purity per dollar — the cheapest that's actually been tested
No prices found for Emoxypine succinate (Mexidol).
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Kimera Chems has the lowest single-vial Emoxypine succinate (Mexidol) price at $0.003/mg among 2 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower.
What is the price range for Emoxypine succinate (Mexidol)?
Research-grade Emoxypine succinate (Mexidol) is listed at $0.003/mg from 1 verified source on Disclosed Labs.
How are Emoxypine succinate (Mexidol) prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Human data: Registered/marketed prescription drug in Russia and CIS states since the 1990s; multiple Russia-conducted trials exist, including a published multicenter double-blind placebo-controlled RCT (MEGA) in 333 children aged 6–12 with ADHD across 14 Russian centers using 125 mg tablets. No FDA/EMA-reviewed pivotal trial or US-marketed product exists; independent non-Russian-sponsored replication is limited. Preclinical: In rats (180–240 g), 6.25–25 mg/kg emoxypine reduced forced-swim-test immobility by ~24% and orientational activity by ~53% (antidepressant-like activity, animal data only). In isolated/anesthetized rat hearts, 10 mg/kg IV increased collateral coronary blood flow without altering systemic blood pressure (animal data only). In vitro (Caco-2/HEK293-SLCO1B1/HepG2 cell lines), the compound inhibited ABCB1 and SLCO1B1 transporters less potently than reference inhibitors; authors judged systemic effect not clinically significant.
This platform provides informational tools only, not medical advice.
Prices verified as of July 2026. Actual prices may vary. For research use only.
2022
Disclosed Labs